Order Article Reprints

Lehtomäki K, Mustonen H, Kellokumpu-Lehtinen P-L, Joensuu H, Hermunen K, Soveri L-M, Boisen MK, Dehlendorff C, Johansen JS, Haglund C, et al. Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer. Cancers. 2021; 13(15):3892. https://doi.org/10.3390/cancers13153892

Lehtomäki, Kaisa, Harri Mustonen, Pirkko-Liisa Kellokumpu-Lehtinen, Heikki Joensuu, Kethe Hermunen, Leena-Maija Soveri, Mogens Karsbøl Boisen, Christian Dehlendorff, Julia Sidenius Johansen, Caj Haglund, and et al. 2021. "Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer" Cancers 13, no. 15: 3892. https://doi.org/10.3390/cancers13153892

Lehtomäki, K., Mustonen, H., Kellokumpu-Lehtinen, P.-L., Joensuu, H., Hermunen, K., Soveri, L.-M., Boisen, M. K., Dehlendorff, C., Johansen, J. S., Haglund, C., & Osterlund, P. (2021). Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer. Cancers, 13(15), 3892. https://doi.org/10.3390/cancers13153892